文献
J-GLOBAL ID:201802216838831025
整理番号:18A2174296
リツキシマブ時代における原発性乳房びまん性大細胞型B細胞リンパ腫:治療戦略及び不成功パターン
Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure
著者 (28件):
Hu Shaoxuan
(Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
,
Song Yuqin
(Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China)
,
Sun Xiuhua
(Department of Medical Oncology, The Second Hospital of Dalian Medical University, Dalian, China)
,
Su Liping
(Department of Hematology, Cancer Hospital of Shanxi Province, Taiyuan, China)
,
Zhang Wei
(Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
,
Jia Jing
(Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China)
,
Bai Ou
(Department of Hematology, The First Hospital of Jilin University, Jilin, China)
,
Yang Sheng
(Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
,
Liang Rong
(Department of Hematology, Xijing Hospital, The Fourth Military Medical University, Xi’an, China)
,
Li Xiaoling
(Department of Medical Oncology, Liaoning Cancer Hospital and Institute, Shenyang, China)
,
Zhang Huilai
(Department of Medical Oncology, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China)
,
Gao Yuhuan
(Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China)
,
Zhang Weijing
(Department of Medical Oncology, 307 Hospital of Chinese People’s Liberation Army, Beijing, China)
,
Xiao Xiubin
(Department of Medical Oncology, 307 Hospital of Chinese People’s Liberation Army, Beijing, China)
,
Bao Huizheng
(Department of Medical Oncology, Jilin Cancer Hospital, Changchun, China)
,
Wang Ningju
(Department of Medical Oncology, General Hospital of Ningxia Medical University, Yinchuan, China)
,
Ren Hanyun
(Department of Hematology, Peking University First Hospital, Beijing, China)
,
Cen Xinan
(Department of Hematology, Peking University First Hospital, Beijing, China)
,
Yang Shun’e
(Department of Medical Oncology, Xinjiang Cancer Hospital, Wulumuqi, China)
,
Zhao Yu
(Department of Hematology, The General Hospital of Chinese People’s Liberation Army, Beijing, China)
,
Wang Yinan
(Department of Medical Oncology, The People’s Hospital of Tangshan City, Tangshan, China)
,
Wang Yalan
(Department of Medical Oncology, Baotou Cancer Hospital, Baotou, China)
,
Liu Aichun
(Department of Hematology, The Third Hospital of Harbin Medical University, Haerbin, China)
,
Wang Jingwen
(Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China)
,
Shi Yuankai
(Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
,
Yuan Ming
(Illinois Institute of Technology, Chicago, Illinois)
,
Li Yufu
(Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China)
,
He Xiaohui
(Department of Medical Oncology, National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China)
資料名:
Cancer Science (Web)
(Cancer Science (Web))
巻:
109
号:
12
ページ:
3943-3952
発行年:
2018年
JST資料番号:
U0505A
ISSN:
1349-7006
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)